Adverum Biotechnologies Inc. (ADVM) NASDAQ

$14.22 (0.45) (-3.03%)

Market Cap: $3.04B

As of 03/28/24 02:28 PM EDT. Market open.

(ADVM)

Adverum Biotechnologies Inc. (ADVM)
NASDAQ

$14.22
(0.45) (-3.03%)

Market Cap: $3.04B

As of 03/28/24 02:28 PM EDT. Market open.

Add to Portfolio

adverum (nasdaq: advm) is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. we are advancing the development of a robust pipeline of gene therapies that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (a1at) deficiency and hereditary angioedema (hae) as well as wet age-related macular degeneration (wamd). ... read more

adverum (nasdaq: advm) is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. we are advancing the development of a robust pipeline of gene therapies that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (a1at) deficiency and hereditary angioedema (hae) as well as wet age-related macular degeneration (wamd). leveraging our next-generation adeno-associated virus (aav)-based directed evolution platform, we generate gene therapies designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Leone Patterson
Full Time Employees
174
CEO Compensation (Base)
$188,300
CEO Compensation (Total)
$2.71M
URL
Address
800 Saginaw Drive, California, Redwood City, 94063.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Leone Patterson
Full Time Employees
174
CEO Compensation (Base)
$188,300
CEO Compensation (Total)
$2.71M
Address
800 Saginaw Drive, California, Redwood City, 94063.
PRICE CHART FOR ADVERUM BIOTECHNOLOGIES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.52
Previous Close
$14.66
Days Range
$13.74 - $15.16
52 week range
$6.81 - $29.70
Volume
59,735
Avg. Volume (30 days)
243,692
Market Cap
$3.04B
Dividend Yield
-
P/E
-
Shares Outstanding
207,549,152
Open
$14.52
Previous Close
$14.66
Days Range
$13.74 - $15.16
52 week range
$6.81 - $29.70
Volume
59,735
Avg. Volume (30 days)
243,692
Market Cap
$3.04B
Dividend Yield
-
P/E
-
Shares Outstanding
207,549,152
FINANCIAL STATEMENTS FOR ADVERUM BIOTECHNOLOGIES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ADVERUM BIOTECHNOLOGIES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Scopa James PaulDirectorFeb 07, 2024 Buy$1.35100,000135,000100,000Feb 09, 2024, 05:51 PM
Lupher, Jr. Mark L.DirectorFeb 07, 2024 Buy$1.35130,000175,500130,000Feb 09, 2024, 05:50 PM
Seyedkazemi SetarehChief Development OfficerSep 15, 2023 Sale$1.526,2019,42947,804Sep 18, 2023, 06:54 PM
Rubinstein Linda MChief Financial OfficerJun 07, 2023 Buy$1.45100,000145,490100,000Jun 09, 2023, 04:26 PM
Riley BrigitChief Scientific OfficerMar 15, 2023 Sale$0.787,2995,705117,435Mar 17, 2023, 06:02 PM
Soparkar PeterChief Operating OfficerMar 15, 2023 Sale$0.7813,36010,442265,891Mar 17, 2023, 06:02 PM
Fischer LaurentCEO, President and DirectorMar 15, 2023 Sale$0.7841,23932,232692,141Mar 17, 2023, 06:01 PM
Beckman RichardChief Medical OfficerSep 19, 2022 Sale$1.074,2724,57039,061Sep 21, 2022, 08:01 PM
Seyedkazemi SetarehChief Development OfficerSep 19, 2022 Sale$1.076,0586,48047,875Sep 21, 2022, 08:00 PM
Soparkar PeterSee Remarks sectionSep 19, 2022 Sale$1.0713,30514,232273,251Sep 21, 2022, 07:59 PM
Riley BrigitChief Scientific OfficerSep 19, 2022 Sale$1.077,2667,772118,734Sep 21, 2022, 07:58 PM
Fischer LaurentCEO, President and DirectorSep 19, 2022 Sale$1.0741,08243,941727,380Sep 21, 2022, 07:57 PM
Seyedkazemi SetarehChief Development OfficerMay 23, 2022 Buy$0.8420,00016,80020,600May 24, 2022, 04:47 PM
Beckman RichardChief Medical OfficerMay 17, 2022 Buy$0.8210,0008,22810,000May 19, 2022, 07:43 PM
Svoronos DawnDirectorMay 16, 2022 Buy$0.8530,00025,57850,000May 18, 2022, 04:43 PM
D'Souza RupertChief Financial OfficerMay 17, 2022 Buy$0.8310,0008,27220,850May 17, 2022, 06:28 PM
D'Souza RupertChief Financial OfficerMay 13, 2022 Buy$0.8610,0008,58510,850May 17, 2022, 06:28 PM
Fischer LaurentCEO, President and DirectorApr 20, 2022 Buy$1.1125,00027,800762,462Apr 22, 2022, 05:00 PM
Soparkar PeterSee Remarks sectionApr 19, 2022 Buy$1.1421,92524,994280,556Apr 20, 2022, 04:35 PM
Fischer LaurentCEO, President and DirectorDec 09, 2021 Buy$1.8514,32326,498737,462Dec 10, 2021, 05:26 PM
Fischer LaurentCEO, President and DirectorDec 08, 2021 Buy$1.7910,67719,112723,139Dec 10, 2021, 05:26 PM
Soparkar PeterSee Remarks sectionDec 08, 2021 Buy$1.9125,00047,750258,631Dec 10, 2021, 05:26 PM
Scopa James PaulDirectorNov 15, 2021 Sale$2.1850,000109,0003,334Nov 17, 2021, 04:38 PM
Clark JulieChief Medical OfficerSep 30, 2021 Sale$2.174,76610,342164,723Oct 04, 2021, 05:36 PM
Svoronos DawnDirectorMar 31, 2021 Buy$10.0220,000200,33820,000Apr 01, 2021, 08:21 PM
Fischer LaurentCEO and DirectorMar 24, 2021 Buy$9.8810,00098,78026,292Mar 24, 2021, 07:47 PM
Machado PatrickDirectorMar 24, 2021 Buy$9.9210,00099,19688,182Mar 24, 2021, 07:46 PM
PATTERSON LEONE DPresident and CFOFeb 09, 2021 Sale$14.1012,533176,71898,017Feb 11, 2021, 07:47 PM
Machado PatrickDirectorJan 15, 2021 Buy$11.5210,000115,17478,182Jan 19, 2021, 08:33 PM
Fischer LaurentCEO and DirectorJan 15, 2021 Buy$11.538,60099,19116,292Jan 19, 2021, 08:32 PM
Soparkar PeterChief Legal OfficerAug 17, 2020 Buy$13.007,69299,99610,692Aug 19, 2020, 06:48 PM
Fischer LaurentCEO and DirectorAug 17, 2020 Buy$13.007,69299,9967,692Aug 19, 2020, 06:45 PM
Gasmi MehdiDirectorJul 20, 2020 Option Exercise$4.805,00024,000279,442Jul 22, 2020, 09:44 PM
Gasmi MehdiDirectorJul 20, 2020 Sale$17.605,00087,978274,442Jul 22, 2020, 09:44 PM
Gasmi MehdiDirectorJun 22, 2020 Option Exercise$4.8023,605113,304298,047Jun 23, 2020, 06:58 PM
Gasmi MehdiDirectorJun 22, 2020 Sale$25.0623,605591,617274,442Jun 23, 2020, 06:58 PM
Gasmi MehdiDirectorJun 17, 2020 Option Exercise$4.802681,286274,710Jun 18, 2020, 09:45 PM
Gasmi MehdiDirectorJun 18, 2020 Option Exercise$4.8011,12753,410285,569Jun 18, 2020, 09:45 PM
Gasmi MehdiDirectorJun 17, 2020 Sale$25.012686,703274,442Jun 18, 2020, 09:45 PM
Gasmi MehdiDirectorJun 18, 2020 Sale$25.0111,127278,329274,442Jun 18, 2020, 09:45 PM
PATTERSON LEONE DPresidentJun 16, 2020 Sale$24.6813,171325,060110,488Jun 17, 2020, 05:47 PM
Gasmi MehdiDirectorJun 15, 2020 Option Exercise$4.8010,00048,000284,442Jun 17, 2020, 05:14 PM
Gasmi MehdiDirectorJun 15, 2020 Sale$21.8610,000218,627279,442Jun 17, 2020, 05:14 PM
Gasmi MehdiDirectorMay 21, 2020 Option Exercise$4.803,59917,275278,041May 22, 2020, 06:55 PM
Gasmi MehdiDirectorMay 20, 2020 Option Exercise$4.801,4016,725275,843May 22, 2020, 06:55 PM
Gasmi MehdiDirectorMay 20, 2020 Sale$20.011,40128,030274,442May 22, 2020, 06:55 PM
Gasmi MehdiDirectorMay 21, 2020 Sale$20.023,59972,048274,442May 22, 2020, 06:55 PM
Gasmi MehdiDirectorMay 05, 2020 Option Exercise$4.8010,00048,000284,442May 20, 2020, 07:34 PM
Gasmi MehdiDirectorMay 18, 2020 Option Exercise$4.805,00024,000279,442May 20, 2020, 07:34 PM
Gasmi MehdiDirectorMay 06, 2020 Option Exercise$4.8025,000120,000299,442May 20, 2020, 07:34 PM
Gasmi MehdiDirectorMay 18, 2020 Sale$18.175,00090,833274,742May 20, 2020, 07:34 PM
Gasmi MehdiDirectorMay 06, 2020 Sale$20.0325,000500,667274,442May 20, 2020, 07:34 PM
Gasmi MehdiDirectorMay 05, 2020 Sale$16.2610,000162,573274,442May 20, 2020, 07:34 PM
Gasmi MehdiDirectorFeb 12, 2020 Option Exercise$12.5646,976589,876289,936May 20, 2020, 07:33 PM
Gasmi MehdiDirectorFeb 12, 2020 Option Exercise$4.8010,00048,000284,442May 20, 2020, 07:33 PM
Gasmi MehdiDirectorFeb 12, 2020 Sale$15.0710,000150,690274,442May 20, 2020, 07:33 PM
PATTERSON LEONE DCEO, President and DirectorMay 06, 2020 Option Exercise$3.4420,00068,800143,659May 08, 2020, 06:25 PM
PATTERSON LEONE DCEO, President and DirectorMay 06, 2020 Sale$20.0220,000400,400123,659May 08, 2020, 06:25 PM
PATTERSON LEONE DCEO, President and DirectorFeb 09, 2020 Option Exercise$10.2410,985112,486139,235May 08, 2020, 06:24 PM
Scopa James PaulDirectorMay 04, 2020 Option Exercise$6.4823,334151,20453,334May 05, 2020, 06:44 PM
PATTERSON LEONE DCEO, President and DirectorMar 20, 2020 Option Exercise$3.4424,42484,019162,955Mar 25, 2020, 05:28 PM
PATTERSON LEONE DCEO, President and DirectorMar 20, 2020 Sale$10.1739,526401,908123,429Mar 25, 2020, 05:28 PM
PATTERSON LEONE DCEO, President and DirectorMar 17, 2020 Sale$10.024744,749138,531Mar 18, 2020, 07:33 PM
Gasmi MehdiDirectorFeb 18, 2020 Option Exercise$4.805,00024,000263,979Feb 20, 2020, 04:51 PM
Gasmi MehdiDirectorFeb 18, 2020 Sale$16.235,00081,156258,979Feb 20, 2020, 04:51 PM
Scopa James PaulDirectorFeb 14, 2020 Buy$13.7510,000137,50030,000Feb 14, 2020, 08:58 PM
Gasmi MehdiDirectorFeb 12, 2020 Option Exercise$12.5646,945589,525289,967Feb 14, 2020, 08:57 PM
Gasmi MehdiDirectorFeb 12, 2020 Option Exercise$4.8010,00048,000268,979Feb 14, 2020, 08:57 PM
Gasmi MehdiDirectorFeb 12, 2020 Sale$15.0710,000150,690258,979Feb 14, 2020, 08:57 PM
Gasmi MehdiDirectorFeb 09, 2020 Option Exercise$10.2415,494158,659274,473Feb 14, 2020, 08:55 PM
Gasmi MehdiDirectorFeb 09, 2020 Option Exercise$10.2411,551118,282309,867Feb 10, 2020, 07:57 AM
PATTERSON LEONE DCEO, President and DirectorFeb 09, 2020 Option Exercise$10.2411,215114,842139,005Feb 10, 2020, 07:56 AM
PATTERSON LEONE DCEO, President and DirectorDec 23, 2019 Sale$10.7240,000428,800150,220Feb 10, 2020, 07:54 AM
Gasmi MehdiDirectorFeb 09, 2018 Option Exercise$7.0511,43380,603259,173Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorAug 21, 2017 Option Exercise$2.505,47913,698270,606Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorApr 21, 2019 Option Exercise$5.985893,522321,418Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorApr 21, 2017 Option Exercise$2.706571,774276,085Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorFeb 12, 2019 Option Exercise$3.5510,65237,815322,007Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorFeb 12, 2017 Option Exercise$3.0012,79338,379276,742Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorFeb 09, 2019 Option Exercise$3.3312,59941,955332,659Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorApr 21, 2018 Option Exercise$6.306053,812247,762Feb 10, 2020, 07:52 AM
Gasmi MehdiDirectorFeb 12, 2018 Option Exercise$6.8510,80674,021248,367Feb 10, 2020, 07:52 AM
PATTERSON LEONE DCEO, President and DirectorJun 15, 2018 Option Exercise$5.558,64547,980242,248Feb 10, 2020, 07:51 AM
PATTERSON LEONE DCEO, President and DirectorFeb 09, 2018 Option Exercise$7.058,20857,866162,397Feb 10, 2020, 07:51 AM
PATTERSON LEONE DCEO, President and DirectorJun 15, 2017 Option Exercise$2.709,39525,367170,605Feb 10, 2020, 07:51 AM
PATTERSON LEONE DCEO, President and DirectorJun 15, 2019 Option Exercise$10.8243,852474,479225,502Feb 10, 2020, 07:51 AM
PATTERSON LEONE DCEO, President and DirectorFeb 09, 2019 Option Exercise$3.338,17627,226234,072Feb 10, 2020, 07:51 AM
PATTERSON LEONE DCEO, President and DirectorDec 23, 2019 Sale$10.7240,000428,800228,496Dec 26, 2019, 04:47 PM
Scopa James PaulDirectorMay 06, 2019 Buy$6.7120,000134,20020,000May 06, 2019, 07:42 PM
Gasmi MehdiSVP,Pharmaceutical DevelopmentJun 15, 2015 Option Exercise$2.755001,3757,500Jun 17, 2015, 08:33 PM
Gasmi MehdiSVP,Pharmaceutical DevelopmentJun 15, 2015 Sale$39.8650019,9317,000Jun 17, 2015, 08:33 PM
Wachter PaulDirectorJun 15, 2015 Sale$39.861,19247,51637,161Jun 17, 2015, 08:33 PM
Schwartz Steven DanielDirectorJun 15, 2015 Sale$39.8616,875672,671367,931Jun 17, 2015, 08:33 PM
Hull HansSVP, Business OperationsJun 12, 2015 Option Exercise$0.198,3001,57719,620Jun 16, 2015, 06:25 PM
Blumenkranz Mark S.DirectorJun 11, 2015 Sale$39.971,90075,939522,989Jun 15, 2015, 05:01 PM
Bain LindaChief Financial OfficerJun 12, 2015 Option Exercise$3.153,50011,02512,500Jun 15, 2015, 05:00 PM
Bain LindaChief Financial OfficerJun 12, 2015 Sale$39.943,500139,7959,000Jun 15, 2015, 05:00 PM
GUERIN JOHN PATRICK ET ALDirectorJun 10, 2015 Sale$206.00699143,994150,000Jun 11, 2015, 09:09 PM
GUERIN JOHN PATRICK ET ALDirectorMay 28, 2015 Sale$208.001208150,699Jun 11, 2015, 09:09 PM
GUERIN JOHN PATRICK ET ALDirectorMay 27, 2015 Sale$206.001,205248,230150,700Jun 11, 2015, 09:09 PM
Blumenkranz Mark S.DirectorJun 10, 2015 Sale$39.9160023,948524,889Jun 11, 2015, 06:21 PM
Blumenkranz Mark S.DirectorJun 09, 2015 Sale$35.7522,500804,328532,689Jun 11, 2015, 06:21 PM
Chalberg Thomas W.Chief Executive OfficerJun 10, 2015 Sale$38.0525,000951,194278,953Jun 11, 2015, 06:21 PM
Wachter PaulDirectorJun 08, 2015 Sale$38.641,19246,06139,004Jun 10, 2015, 08:29 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentJun 08, 2015 Option Exercise$2.755001,3757,500Jun 10, 2015, 08:28 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentJun 08, 2015 Sale$38.6450019,3217,265Jun 10, 2015, 08:28 PM
Blumenkranz Mark S.DirectorJun 05, 2015 Sale$40.085,000200,414547,989Jun 08, 2015, 05:20 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 28, 2015 Option Exercise$2.755001,3757,500Jun 05, 2015, 08:00 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 28, 2015 Sale$38.0250019,0097,000Jun 05, 2015, 08:00 PM
Hull HansSVP, Business OperationsJun 04, 2015 Option Exercise$0.192,00038013,320Jun 05, 2015, 05:59 PM
Hull HansSVP, Business OperationsJun 04, 2015 Sale$37.642,00075,28311,320Jun 05, 2015, 05:59 PM
Wachter PaulDirectorJun 01, 2015 Sale$36.231,19243,19139,755Jun 02, 2015, 08:24 PM
Schwartz Steven DanielDirectorJun 01, 2015 Sale$36.2317,250625,043387,899Jun 02, 2015, 08:24 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 28, 2015 Option Exercise$2.755001,3757,500May 29, 2015, 02:37 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 28, 2015 Sale$38.0250019,0097,000May 29, 2015, 02:37 PM
Wachter PaulDirectorMay 26, 2015 Sale$36.941,19244,03741,143May 27, 2015, 06:39 PM
Schwartz Steven DanielDirectorMay 22, 2015 Sale$38.3816,875647,687407,252May 22, 2015, 07:21 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 21, 2015 Option Exercise$2.755001,3757,500May 22, 2015, 04:36 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 21, 2015 Sale$38.8750019,4357,000May 22, 2015, 04:36 PM
Blumenkranz Mark S.DirectorMay 19, 2015 Sale$36.913,000110,73410,531May 21, 2015, 05:53 PM
Wachter PaulDirectorMay 18, 2015 Sale$35.311,19242,08641,929May 19, 2015, 06:24 PM
Blumenkranz Mark S.DirectorMay 15, 2015 Sale$35.4922,500798,553557,514May 18, 2015, 05:22 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 14, 2015 Option Exercise$2.755001,3757,500May 15, 2015, 05:47 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 14, 2015 Sale$35.3150017,6567,000May 15, 2015, 05:47 PM
Blumenkranz Mark S.DirectorMay 13, 2015 Sale$34.9471524,984575,489May 13, 2015, 07:16 PM
Bain LindaChief Financial OfficerMay 13, 2015 Option Exercise$3.152858989,285May 13, 2015, 07:15 PM
Bain LindaChief Financial OfficerMay 13, 2015 Sale$34.942859,9599,000May 13, 2015, 07:15 PM
Wachter PaulDirectorMay 11, 2015 Sale$33.381,19239,79243,805May 12, 2015, 05:05 PM
Bain LindaChief Financial OfficerMay 11, 2015 Option Exercise$3.157152,2529,715May 12, 2015, 05:03 PM
Bain LindaChief Financial OfficerMay 11, 2015 Sale$34.9171524,9649,000May 12, 2015, 05:03 PM
Blumenkranz Mark S.DirectorMay 11, 2015 Sale$34.911,78562,323576,204May 12, 2015, 05:00 PM
Schwartz Steven DanielDirectorMay 08, 2015 Sale$33.0517,250570,092418,931May 11, 2015, 05:00 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 07, 2015 Option Exercise$2.755001,3757,500May 08, 2015, 07:09 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentMay 07, 2015 Sale$33.2850016,6387,000May 08, 2015, 07:09 PM
Chalberg Thomas W.Chief Executive OfficerMay 05, 2015 Sale$30.0025,000750,093283,988May 07, 2015, 04:16 PM
Hull HansSVP, Business OperationsMay 04, 2015 Option Exercise$0.195,00095016,320May 06, 2015, 04:06 PM
Hull HansSVP, Business OperationsMay 04, 2015 Sale$30.875,000154,34911,320May 06, 2015, 04:06 PM
Bain LindaChief Financial OfficerMay 04, 2015 Option Exercise$3.152,5007,87511,500May 06, 2015, 04:06 PM
Bain LindaChief Financial OfficerMay 04, 2015 Sale$31.592,50078,9729,000May 06, 2015, 04:06 PM
Wachter PaulDirectorMay 04, 2015 Sale$30.871,19236,79744,313May 06, 2015, 04:05 PM
Blumenkranz Mark S.DirectorMay 01, 2015 Sale$32.3720,000647,306577,989May 05, 2015, 04:06 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 28, 2015 Option Exercise$2.751,0002,7508,000Apr 30, 2015, 06:51 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 28, 2015 Sale$35.671,00035,6677,000Apr 30, 2015, 06:51 PM
Wachter PaulDirectorApr 27, 2015 Sale$35.611,19242,44345,505Apr 29, 2015, 05:47 PM
Schwartz Steven DanielDirectorApr 23, 2015 Sale$38.6216,875651,665436,181Apr 23, 2015, 07:52 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 21, 2015 Option Exercise$2.751,0002,7501,000Apr 23, 2015, 04:58 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 21, 2015 Sale$39.211,00039,2110Apr 23, 2015, 04:58 PM
Wachter PaulDirectorApr 20, 2015 Sale$40.191,19247,91046,697Apr 21, 2015, 05:49 PM
Blumenkranz Mark S.DirectorApr 16, 2015 Sale$41.5925,0001,039,753596,189Apr 20, 2015, 05:37 PM
Zygtech, LLC10% OwnerApr 14, 2015 Sale$39.934,600183,6632,438,176Apr 15, 2015, 05:25 PM
Zygtech, LLC10% OwnerApr 13, 2015 Sale$39.4620,400805,0092,450,902Apr 15, 2015, 05:25 PM
Wachter PaulDirectorApr 13, 2015 Sale$39.341,19246,89648,251Apr 15, 2015, 05:25 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 14, 2015 Option Exercise$2.751,0002,7501,000Apr 15, 2015, 05:24 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 14, 2015 Sale$39.451,00039,4480Apr 15, 2015, 05:24 PM
Schwartz Steven DanielDirectorApr 09, 2015 Sale$39.7317,250685,278451,256Apr 13, 2015, 04:47 PM
Blumenkranz Mark S.DirectorApr 07, 2015 Sale$38.6022,500868,560624,215Apr 08, 2015, 04:47 PM
Blumenkranz Mark S.DirectorApr 07, 2015 Sale$38.603,000115,80811,563Apr 08, 2015, 04:47 PM
Blumenkranz Mark S.DirectorApr 08, 2015 Sale$39.942,50099,841620,989Apr 08, 2015, 04:47 PM
Hull HansSVP, Business OperationsApr 07, 2015 Option Exercise$0.1927,5005,22530,820Apr 08, 2015, 04:32 PM
Hull HansSVP, Business OperationsApr 07, 2015 Sale$38.6027,5001,061,5734,207Apr 08, 2015, 04:32 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 07, 2015 Option Exercise$2.759,00024,7509,000Apr 08, 2015, 04:29 PM
Gasmi MehdiVP, Pharmaceutical DevelopmentApr 07, 2015 Sale$38.609,000347,425292Apr 08, 2015, 04:29 PM
Zygtech, LLC10% OwnerJan 13, 2015 Sale$55.46100,0005,546,0002,463,176Jan 15, 2015, 05:00 PM
Wachter PaulDirectorJan 13, 2015 Sale$55.4614,000776,44049,081Jan 15, 2015, 04:59 PM
Schwartz Steven DanielDirectorJan 13, 2015 Sale$55.4691,0005,046,860468,306Jan 15, 2015, 04:58 PM
Chalberg Thomas W.Chief Executive OfficerJan 13, 2015 Sale$55.4685,0004,714,100285,988Jan 15, 2015, 04:58 PM
Blumenkranz Mark S.DirectorJan 13, 2015 Sale$55.46100,0005,546,000645,989Jan 15, 2015, 04:57 PM
Chalberg Thomas W.Chief Executive OfficerDec 12, 2014 Option Exercise$0.2141387371,401Jan 14, 2015, 05:43 PM
Venrock Healthcare Capital Partners II, L.P.10% OwnerAug 05, 2014 Buy$17.00400,0006,800,0002,365,471Aug 07, 2014, 03:18 PM
Venrock Associates VI, L.P.10% OwnerAug 05, 2014 Buy$17.00400,0006,800,0002,365,471Aug 07, 2014, 03:17 PM
Schwartz Steven DanielDirectorAug 05, 2014 Option Exercise$0.1534,0005,100534,000Aug 07, 2014, 03:11 PM
Blumenkranz Mark S.DirectorAug 05, 2014 Option Exercise$0.1525,0003,750725,000Aug 07, 2014, 03:07 PM
REGENERON PHARMACEUTICALS INC10% OwnerAug 05, 2014 Buy$17.00588,2359,999,9951,809,098Aug 05, 2014, 05:39 PM
Flynn James E10% OwnerAug 05, 2014 Buy$17.0042,700725,900227,294Aug 05, 2014, 05:26 PM
Flynn James E10% OwnerAug 05, 2014 Buy$25.14627,26715,770,984627,267Aug 05, 2014, 05:26 PM
Flynn James E10% OwnerAug 05, 2014 Buy$25.14507,20012,752,446507,200Aug 05, 2014, 05:26 PM
Flynn James E10% OwnerAug 05, 2014 Buy$17.00123,0772,092,309654,285Aug 05, 2014, 05:26 PM
Flynn James E10% OwnerAug 05, 2014 Buy$17.0034,223581,791181,633Aug 05, 2014, 05:26 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Scopa James PaulDirector02/07/2024135,000
Lupher, Jr. Mark L.Director02/07/2024175,500
Seyedkazemi SetarehChief Development Officer09/15/20239,429
Rubinstein Linda MChief Financial Officer06/07/2023145,490
Riley BrigitChief Scientific Officer03/15/20235,705
Soparkar PeterChief Operating Officer03/15/202310,442
Fischer LaurentCEO, President and Director03/15/202332,232
Beckman RichardChief Medical Officer09/19/20224,570
Seyedkazemi SetarehChief Development Officer09/19/20226,480
Soparkar PeterSee Remarks section09/19/202214,232
Riley BrigitChief Scientific Officer09/19/20227,772
Fischer LaurentCEO, President and Director09/19/202243,941
Seyedkazemi SetarehChief Development Officer05/23/202216,800
Beckman RichardChief Medical Officer05/17/20228,228
Svoronos DawnDirector05/16/202225,578
D'Souza RupertChief Financial Officer05/17/20228,272
D'Souza RupertChief Financial Officer05/13/20228,585
Fischer LaurentCEO, President and Director04/20/202227,800
Soparkar PeterSee Remarks section04/19/202224,994
Fischer LaurentCEO, President and Director12/09/202126,498
Fischer LaurentCEO, President and Director12/08/202119,112
Soparkar PeterSee Remarks section12/08/202147,750
Scopa James PaulDirector11/15/2021109,000
Clark JulieChief Medical Officer09/30/202110,342
Svoronos DawnDirector03/31/2021200,338
Fischer LaurentCEO and Director03/24/202198,780
Machado PatrickDirector03/24/202199,196
PATTERSON LEONE DPresident and CFO02/09/2021176,718
Machado PatrickDirector01/15/2021115,174
Fischer LaurentCEO and Director01/15/202199,191
Soparkar PeterChief Legal Officer08/17/202099,996
Fischer LaurentCEO and Director08/17/202099,996
Gasmi MehdiDirector07/20/202024,000
Gasmi MehdiDirector07/20/202087,978
Gasmi MehdiDirector06/22/2020113,304
Gasmi MehdiDirector06/22/2020591,617
Gasmi MehdiDirector06/17/20201,286
Gasmi MehdiDirector06/18/202053,410
Gasmi MehdiDirector06/17/20206,703
Gasmi MehdiDirector06/18/2020278,329
PATTERSON LEONE DPresident06/16/2020325,060
Gasmi MehdiDirector06/15/202048,000
Gasmi MehdiDirector06/15/2020218,627
Gasmi MehdiDirector05/21/202017,275
Gasmi MehdiDirector05/20/20206,725
Gasmi MehdiDirector05/20/202028,030
Gasmi MehdiDirector05/21/202072,048
Gasmi MehdiDirector05/05/202048,000
Gasmi MehdiDirector05/18/202024,000
Gasmi MehdiDirector05/06/2020120,000
Gasmi MehdiDirector05/18/202090,833
Gasmi MehdiDirector05/06/2020500,667
Gasmi MehdiDirector05/05/2020162,573
Gasmi MehdiDirector02/12/2020589,876
Gasmi MehdiDirector02/12/202048,000
Gasmi MehdiDirector02/12/2020150,690
PATTERSON LEONE DCEO, President and Director05/06/202068,800
PATTERSON LEONE DCEO, President and Director05/06/2020400,400
PATTERSON LEONE DCEO, President and Director02/09/2020112,486
Scopa James PaulDirector05/04/2020151,204
PATTERSON LEONE DCEO, President and Director03/20/202084,019
PATTERSON LEONE DCEO, President and Director03/20/2020401,908
PATTERSON LEONE DCEO, President and Director03/17/20204,749
Gasmi MehdiDirector02/18/202024,000
Gasmi MehdiDirector02/18/202081,156
Scopa James PaulDirector02/14/2020137,500
Gasmi MehdiDirector02/12/2020589,525
Gasmi MehdiDirector02/12/202048,000
Gasmi MehdiDirector02/12/2020150,690
Gasmi MehdiDirector02/09/2020158,659
Gasmi MehdiDirector02/09/2020118,282
PATTERSON LEONE DCEO, President and Director02/09/2020114,842
PATTERSON LEONE DCEO, President and Director12/23/2019428,800
Gasmi MehdiDirector02/09/201880,603
Gasmi MehdiDirector08/21/201713,698
Gasmi MehdiDirector04/21/20193,522
Gasmi MehdiDirector04/21/20171,774
Gasmi MehdiDirector02/12/201937,815
Gasmi MehdiDirector02/12/201738,379
Gasmi MehdiDirector02/09/201941,955
Gasmi MehdiDirector04/21/20183,812
Gasmi MehdiDirector02/12/201874,021
PATTERSON LEONE DCEO, President and Director06/15/201847,980
PATTERSON LEONE DCEO, President and Director02/09/201857,866
PATTERSON LEONE DCEO, President and Director06/15/201725,367
PATTERSON LEONE DCEO, President and Director06/15/2019474,479
PATTERSON LEONE DCEO, President and Director02/09/201927,226
PATTERSON LEONE DCEO, President and Director12/23/2019428,800
Scopa James PaulDirector05/06/2019134,200
Gasmi MehdiSVP,Pharmaceutical Development06/15/20151,375
Gasmi MehdiSVP,Pharmaceutical Development06/15/201519,931
Wachter PaulDirector06/15/201547,516
Schwartz Steven DanielDirector06/15/2015672,671
Hull HansSVP, Business Operations06/12/20151,577
Blumenkranz Mark S.Director06/11/201575,939
Bain LindaChief Financial Officer06/12/201511,025
Bain LindaChief Financial Officer06/12/2015139,795
GUERIN JOHN PATRICK ET ALDirector06/10/2015143,994
GUERIN JOHN PATRICK ET ALDirector05/28/2015208
GUERIN JOHN PATRICK ET ALDirector05/27/2015248,230
Blumenkranz Mark S.Director06/10/201523,948
Blumenkranz Mark S.Director06/09/2015804,328
Chalberg Thomas W.Chief Executive Officer06/10/2015951,194
Wachter PaulDirector06/08/201546,061
Gasmi MehdiVP, Pharmaceutical Development06/08/20151,375
Gasmi MehdiVP, Pharmaceutical Development06/08/201519,321
Blumenkranz Mark S.Director06/05/2015200,414
Gasmi MehdiVP, Pharmaceutical Development05/28/20151,375
Gasmi MehdiVP, Pharmaceutical Development05/28/201519,009
Hull HansSVP, Business Operations06/04/2015380
Hull HansSVP, Business Operations06/04/201575,283
Wachter PaulDirector06/01/201543,191
Schwartz Steven DanielDirector06/01/2015625,043
Gasmi MehdiVP, Pharmaceutical Development05/28/20151,375
Gasmi MehdiVP, Pharmaceutical Development05/28/201519,009
Wachter PaulDirector05/26/201544,037
Schwartz Steven DanielDirector05/22/2015647,687
Gasmi MehdiVP, Pharmaceutical Development05/21/20151,375
Gasmi MehdiVP, Pharmaceutical Development05/21/201519,435
Blumenkranz Mark S.Director05/19/2015110,734
Wachter PaulDirector05/18/201542,086
Blumenkranz Mark S.Director05/15/2015798,553
Gasmi MehdiVP, Pharmaceutical Development05/14/20151,375
Gasmi MehdiVP, Pharmaceutical Development05/14/201517,656
Blumenkranz Mark S.Director05/13/201524,984
Bain LindaChief Financial Officer05/13/2015898
Bain LindaChief Financial Officer05/13/20159,959
Wachter PaulDirector05/11/201539,792
Bain LindaChief Financial Officer05/11/20152,252
Bain LindaChief Financial Officer05/11/201524,964
Blumenkranz Mark S.Director05/11/201562,323
Schwartz Steven DanielDirector05/08/2015570,092
Gasmi MehdiVP, Pharmaceutical Development05/07/20151,375
Gasmi MehdiVP, Pharmaceutical Development05/07/201516,638
Chalberg Thomas W.Chief Executive Officer05/05/2015750,093
Hull HansSVP, Business Operations05/04/2015950
Hull HansSVP, Business Operations05/04/2015154,349
Bain LindaChief Financial Officer05/04/20157,875
Bain LindaChief Financial Officer05/04/201578,972
Wachter PaulDirector05/04/201536,797
Blumenkranz Mark S.Director05/01/2015647,306
Gasmi MehdiVP, Pharmaceutical Development04/28/20152,750
Gasmi MehdiVP, Pharmaceutical Development04/28/201535,667
Wachter PaulDirector04/27/201542,443
Schwartz Steven DanielDirector04/23/2015651,665
Gasmi MehdiVP, Pharmaceutical Development04/21/20152,750
Gasmi MehdiVP, Pharmaceutical Development04/21/201539,211
Wachter PaulDirector04/20/201547,910
Blumenkranz Mark S.Director04/16/20151,039,753
Zygtech, LLC10% Owner04/14/2015183,663
Zygtech, LLC10% Owner04/13/2015805,009
Wachter PaulDirector04/13/201546,896
Gasmi MehdiVP, Pharmaceutical Development04/14/20152,750
Gasmi MehdiVP, Pharmaceutical Development04/14/201539,448
Schwartz Steven DanielDirector04/09/2015685,278
Blumenkranz Mark S.Director04/07/2015868,560
Blumenkranz Mark S.Director04/07/2015115,808
Blumenkranz Mark S.Director04/08/201599,841
Hull HansSVP, Business Operations04/07/20155,225
Hull HansSVP, Business Operations04/07/20151,061,573
Gasmi MehdiVP, Pharmaceutical Development04/07/201524,750
Gasmi MehdiVP, Pharmaceutical Development04/07/2015347,425
Zygtech, LLC10% Owner01/13/20155,546,000
Wachter PaulDirector01/13/2015776,440
Schwartz Steven DanielDirector01/13/20155,046,860
Chalberg Thomas W.Chief Executive Officer01/13/20154,714,100
Blumenkranz Mark S.Director01/13/20155,546,000
Chalberg Thomas W.Chief Executive Officer12/12/201487
Venrock Healthcare Capital Partners II, L.P.10% Owner08/05/20146,800,000
Venrock Associates VI, L.P.10% Owner08/05/20146,800,000
Schwartz Steven DanielDirector08/05/20145,100
Blumenkranz Mark S.Director08/05/20143,750
REGENERON PHARMACEUTICALS INC10% Owner08/05/20149,999,995
Flynn James E10% Owner08/05/2014725,900
Flynn James E10% Owner08/05/201415,770,984
Flynn James E10% Owner08/05/201412,752,446
Flynn James E10% Owner08/05/20142,092,309
Flynn James E10% Owner08/05/2014581,791
Load More Insider Transactions
FUNDS WITH A POSITION IN ADVERUM BIOTECHNOLOGIES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC1,877,6520.00219%41.2%Other
BLACKROCK INC.1,401,1800.00003%-0.00771%Other
GEODE CAPITAL MANAGEMENT, LLC864,2060.00007%No changeOther
CHANGE IN SHARES OUTSTANDING FOR ADVERUM BIOTECHNOLOGIES INC
STOCK BUYBACKS FOR ADVERUM BIOTECHNOLOGIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.22%
1Q
12/31/2023
06/30/2023
0.45%
2Q
12/31/2023
03/31/2023
0.91%
3Q
12/31/2023
12/31/2022
1.29%
4Q
12/31/2023
09/30/2022
1.75%
5Q
12/31/2023
06/30/2022
2.24%
6Q
12/31/2023
03/31/2022
2.66%
7Q
12/31/2023
12/31/2021
3.01%
8Q
12/31/2023
09/30/2021
3.15%
9Q
12/31/2023
06/30/2021
3.26%
10Q
12/31/2023
03/31/2021
3.55%
11Q
12/31/2023
12/31/2020
3.71%
12Q
12/31/2023
09/30/2020
13.90%
13Q
12/31/2023
06/30/2020
26.16%
14Q
12/31/2023
03/31/2020
37.16%
15Q
12/31/2023
12/31/2019
55.44%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
0.45%
2Q
03/31/2023
0.91%
3Q
12/31/2022
1.29%
4Q
09/30/2022
1.75%
5Q
06/30/2022
2.24%
6Q
03/31/2022
2.66%
7Q
12/31/2021
3.01%
8Q
09/30/2021
3.15%
9Q
06/30/2021
3.26%
10Q
03/31/2021
3.55%
11Q
12/31/2020
3.71%
12Q
09/30/2020
13.90%
13Q
06/30/2020
26.16%
14Q
03/31/2020
37.16%
15Q
12/31/2019
55.44%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ADVERUM BIOTECHNOLOGIES INC
LOADING...